JAMA Network

•

頻道 • 21 個節目

醫學

醫學

每星期更新
醫學

醫學

每兩個月更新
醫學

醫學

每兩星期更新
醫學

醫學

11/05/2020更新
醫學

醫學

每兩個月更新
醫學

醫學

每兩個月更新
醫學

醫學

24/02/2025更新

15/08/2025

The Impact of Nonhealth Policies in a Time of Policy Disruption

The second Trump administration launched several actions in 2025 that directly affect the health of populations. Sara Bleich, PhD, of Harvard Chan School of Public Health joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to discuss the nonhealth policies that may matter most to health and warrant ever-more attention, particularly in a moment of policy turbulence. Related Content: The Health Consequences of Nonhealth Policies in a Time of Policy Disruption

15/08/2025

•

23 分鐘
19/05/2015

Stroke Prevention in Atrial Fibrillation

Edward H. Livingston, MD discusses stroke prevention in atrial fibrillation with Gregory Lip, MD, author of Stroke Prevention in Atrial Fibrillation: A Systematic Review

19/05/2015

•

19 分鐘
12/05/2015

Achalasia

Read the article and earn CME: bit.ly/1T3EpB1 Patient Page: bit.ly/1T3Exk0 Spanish Patient Page (Acalasia): bit.ly/1T3EHrr Understanding the swallowing disorders dysphagia and achalasia as explained by John Pandolfino, MD from Northwestern University. Dr Pandolfino describes how to examine patients with these disorders and how these diseases should be treated.

12/05/2015

•

19 分鐘
17/12/2025

WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

17/12/2025

•

34 分鐘
13/06/2025

Improving Health and Health Care Affordability in the US with David Cutler

The US is an outlier in health system performance, spending more than other peer countries while performing worse. US economist David Cutler, who is the Otto Eckstein Professor of Applied Economics at Harvard University, discusses this and more with JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH. Related Content: On Making US Health Care Great and Affordable

13/06/2025

•

22 分鐘
26/12/2024

Chronic Kidney Disease and Diabetes

Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH. Related Content: Diabetes and Chronic Kidney Disease

26/12/2024

•

18 分鐘
19/09/2025

Cardiovascular Highlights From ESC 2025

Updates on GLP-1 drugs in heart failure, β-blockers after myocardial infarction, the shingles vaccine, and more: Felix Mahfoud, MD, chair of the Department of Cardiology at University Hospital Basel, shares clinical research highlights from the recent European Society of Cardiology Congress. Related Content: GLP-1 Drugs in Heart Failure, β-Blockers After MI, the Shingles Vaccine, and More From ESC 2025

19/09/2025

•

17 分鐘
15/11/2024

The Ethics of AI as Clinical Decision Maker

A recent JAMA Cardiology essay argues that medicine is not just a technical endeavor, it's also a moral endeavor, and a robot does not have moral agency. Coauthor Sarah C. Hull, MD, MBE, of Yale School of Medicine, joins JAMA and JAMA+ AI Associate Editor Yulin Hswen, ScD, MPH, to discuss the use of AI in managing decision-making in cardiac care. Related Content: AI Can't Worry About Patients, and a Clinical Ethicist Says That Matters Echoes of Concern—AI and Moral Agency in Medicine

15/11/2024

•

24 分鐘
11/09/2025

How Did Cystic Fibrosis Go From Fatal to Treatable?

Pulmonologist Michael J. Welsh, MD, is the co-recipient of the 2025 Lasker-DeBakey Clinical Medical Research Award for his research on cystic fibrosis. In this interview, he discusses his early clinical encounters with the disease, the foundational work that led to the lifesaving drug Trikafta, and future directions for cystic fibrosis treatment. Related Content: How Cystic Fibrosis Went From Fatal to Treatable Rewriting the Chapter on Cystic Fibrosis

11/09/2025

•

23 分鐘
21/03/2025

AI's Role in Advancing Equity for Individuals With Developmental Disabilities

Artificial intelligence (AI) in health care is advancing, despite concerns about how its use may impact health disparities. Dimitri Christakis, MD, MPH, chief health officer at Special Olympics, joins JAMA Associate Editor Yulin Hswen, ScD, MPH, to discuss AI's potential role in improving health care delivery for people with intellectual and developmental disabilities. Related Content: How AI Could Improve Health Care for People With Intellectual and Developmental Disabilities How Artificial Intelligence Can Promote Inclusive Health

21/03/2025

•

14 分鐘

JAMA Network™ is a collection of 13 medical journals spanning specialties and general medicine. JN podcasts include Editor summaries, author interviews, conversations, clinical updates and more.